September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...
September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...
September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...
September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...
September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...
September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...
September 07, 2022
